1068
Facebook Twitter instagram Youtube
dr-suhas-singla

Dr. Suhas Singla

Director

Radiology & Imaging

MD - AIIMS Delhi, MBBS - UCMS and GTB Hospital

About Dr. Suhas Singla

Pioneered 177Lu-DOTATATE therapy in India (2007)

Introduced 177Lu-PSMA and 177Lu-DOTATATE therapy in Noida

Trained at AIIMS, New Delhi

Dr. Suhas Singla is a highly experienced nuclear medicine specialist with an MD in nuclear medicine from the All India Institute of Medical Sciences, Delhi. With expertise in both diagnostic and therapeutic applications, he is proficient in PET-CT, SPECT-CT, and targeted molecular therapies. He pioneered the initiation of 177Lu-DOTATATE therapy in India under the mentorship of Prof. C.S. Bal at AIIMS, Delhi, and later introduced both 177Lu-PSMA and 177Lu-DOTATATE therapies in Noida. With over 14 international publications, Dr. Singla combines innovation with evidence-based practice to deliv... Continue Reading

Specialization and Expertise

diagnostic-oncoimaging-with-fdg-psma-dopa-choline-nota-pet-ct Diagnostic oncoimaging with FDG, PSMA, DOPA, Choline, NOTA PET-CT Diagnostic oncoimaging with FDG, PSMA, DOPA, Choline, NOTA PET-CT
all-spect-ct-procedures All SPECT-CT procedures All SPECT-CT procedures
177lu-dotatate-therapy-for-unresectable-neuroendocrine-tumours 177Lu-DOTATATE therapy for unresectable neuroendocrine tumours 177Lu-DOTATATE therapy for unresectable neuroendocrine tumours
177lu-psma-therapy-for-advanced-castrate-resistant-prostate-cancer 177Lu-PSMA therapy for advanced castrate-resistant prostate cancer 177Lu-PSMA therapy for advanced castrate-resistant prostate cancer

Milestones Achieved

Initiated 177Lu-DOTATATE therapy for the first time in India (2007)
2007
Initiated 177Lu-PSMA and 177Lu-DOTATATE therapy in Noida
2008
Back to top